首页 | 本学科首页   官方微博 | 高级检索  
     

佛波酯慢性处理对大鼠血管平滑肌细胞各亚型蛋白激酶C表达的影响
引用本文:周慧轩,周全红,汪燕,江伟,王莉. 佛波酯慢性处理对大鼠血管平滑肌细胞各亚型蛋白激酶C表达的影响[J]. 上海交通大学学报(医学版), 2013, 0(12): 1560-1565,1572
作者姓名:周慧轩  周全红  汪燕  江伟  王莉
作者单位:上海交通大学附属第六人民医院麻醉科,上海200233
基金项目:国家自然科学基金(30972842)
摘    要:目的观察佛波酯(PMA)慢性处理大鼠血管平滑肌细胞各亚型蛋白激酶C(PKCs)表达的影响。方法原代培养大鼠m管平滑肌细胞,①按照PMA处理浓度将细胞随机分为空白组、0.25%eDMSO组和PMAI、5、10μmol/L组,各组细胞均处理4h;②按照PMA处理时间将细胞随机分为空白组、0.25%eDMSO组和PMA1、4和24h组,PMA组的药物浓度均为10μmol/L。采用Western blotting技术榆测各亚型PKCs蛋白的表达。结果PMA浓度〈10μmol/L处理细胞时间〈4h不影响PKC—α的表达(P〉0.05),10pmlol/LPMA处理24h能抑制PKC—α的表达(P〈0.05);PMA浓度〉5μmol/L处理细胞时间〉4h可明显抑制PKC-δ的表达(P〈0.01),PMA浓度〈5μmlol/L处理细胞时间〈4h对PKC-δ的表达无显著影响(P〉0.05),10μmol/LPMA处理细胞1h即可明显抑制PKC-δ的表达(P〈0.01);PMA浓度〉5pμmol/L处理细胞时间〉4h可以明显抑制PKC-θ的表达(P〈0.01);10μmol/L的PMA处理细胞24h对PKC.∈的表达无明显影响(P〉0.05)。结论PMA慢性处理大鼠血管平滑肌细胞可抑制传统型PKC—α和新型PKC-δ、ε、θ的表达,对非典型PKC-ζ的表达没有影响。

关 键 词:佛波酯  血管平滑肌细胞  蛋白激酶C

Changes of protein kinase C isoforms in rat vascular smooth muscle cells treated with prolonged incubation of PMA
ZHOU Hui-xuan,ZHOU Quan-hong,WANG Yan,JIANG Wei,WANG Li. Changes of protein kinase C isoforms in rat vascular smooth muscle cells treated with prolonged incubation of PMA[J]. Journal of Shanghai Jiaotong University:Medical Science, 2013, 0(12): 1560-1565,1572
Authors:ZHOU Hui-xuan  ZHOU Quan-hong  WANG Yan  JIANG Wei  WANG Li
Affiliation:(Department of Anesthesiology, the Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, China)
Abstract:Objective To investigate the changes of protein kinase C (PKC) isoforms in rat vascular smooth muscle cells (VSMCs) treated with prolonged incubation of phorbol-12-myristate-13-acetate (PMA). Methods Primary rat vascular smooth muscle cells cultured in vitro were divided into blank group, 1, 5, and 10 μmol/L PMA-treated groups, and 0.25%v DMSO-treated group, and all cells were treated for 4 h. The other cells were treated with 10 μmol/L PMA for 1, 4, and 24 h and with 0.25% DMSO for 24 h. The levels of PKCs were measured using Western blotting. Results In 1, 5, and 10 μmol/L PMA-treated groups for 4 h, the levels of PKC-α had no significant changes (P 〉 0.05), while in 10 μmol/L PMA-treated group for 24 h, PKC-α was down-regulated significantly (P 〈 0.05). PKC-α expression was down-regulated obviously in VSMCs treated with PMA (〉5 μmol/L for over 4 h)(P 〈 0.01). PKC-α expression had no changes in PMA- treated groups (〈 5 μmol/L shorter than 4 h) (P 〉 0.05), while PKC-α decreased remarkably in PMA group ( 10μmol/L for 1 h) (P 〈 0.01). PKC-0 expression was down-regulated obviously in VSMCs treated with PMA ( 〉 5 μmol/L for over 4 h)(P 〈 0.01). Level of PKC-μ had no changes in PMA group (10 μmol/L for 24 h)(P 〉 0.05). Conclusion Prolonged treatment with PMA down-regulated classical PKC-α and novel PKC- δ, ε, and θ in VSMCs, while had no effect on atypical PKC-ζ.
Keywords:phorbol-12-myristate-13-acetate  vascular smooth muscle cells  protein kinase C
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号